788
Views
34
CrossRef citations to date
0
Altmetric
Research Article

A Novel B-cell Line (U-2932) Established from a Patient with Diffuse Large B-cell Lymphoma Following Hodgkin Lymphoma

, , , , , , , , & show all
Pages 2179-2189 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Grace K. Gifford, Andrew J. Gifford, Qian Chen, Yandong Shen, Sara Gabrielli, Anthony J. Gill, William S. Stevenson & Oliver Giles Best. (2020) Fatty acid synthase and adenosine monophosphate-activated protein kinase regulate cell survival and drug sensitivity in diffuse large B-cell lymphoma. Leukemia & Lymphoma 61:8, pages 1810-1822.
Read now
Muhammad Sharif Hasni, Mattias Berglund, Konstantin Yakimchuk, Jiyu Guan, Johan Linderoth, Rose Marie Amini, Gunilla Enblad & Sam Okret. (2017) Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker. Leukemia & Lymphoma 58:2, pages 418-427.
Read now
Ana A Tula-Sanchez, Aaron P Havas, Peter J Alonge, Mary E Klein, Samantha R Doctor, William Pinkston, Betty J Glinsmann-Gibson, Lisa M Rimsza & Catharine L Smith. (2013) A model of sensitivity and resistance to histone deacetylase inhibitors in diffuse large B cell lymphoma. Cancer Biology & Therapy 14:10, pages 949-961.
Read now
Steve A. Maxwell, Evan M. Cherry & Kayla J. Bayless. (2011) Akt, 14-3-3ζ, and vimentin mediate a drug-resistant invasive phenotype in diffuse large B-cell lymphoma. Leukemia & Lymphoma 52:5, pages 849-864.
Read now
Aarthi Jayanthan, Scott C. Howard, Tanya Trippett, Terzah Horton, James A. Whitlock, Lara Daisley, Victor Lewis & Aru Narendran. (2009) Targeting the Bcl-2 family of proteins in Hodgkin lymphoma: cytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737. Leukemia & Lymphoma 50:7, pages 1174-1182.
Read now

Articles from other publishers (29)

Jessie S. Kroonen, Ilona J. de Graaf, Sumit Kumar, Dennis F. G. Remst, Anne K. Wouters, Mirjam H. M. Heemskerk & Alfred C. O. Vertegaal. (2023) Inhibition of SUMOylation enhances DNA hypomethylating drug efficacy to reduce outgrowth of hematopoietic malignancies. Leukemia 37:4, pages 864-876.
Crossref
Ryohei Kozaki, Tomoko Yasuhiro, Hikaru Kato, Jun Murai, Shingo Hotta, Yuko Ariza, Shunsuke Sakai, Ryu Fujikawa & Takao Yoshida. (2023) Investigation of the anti-tumor mechanism of tirabrutinib, a highly selective Bruton’s tyrosine kinase inhibitor, by phosphoproteomics and transcriptomics. PLOS ONE 18:3, pages e0282166.
Crossref
Matylda Kubacz, Aleksandra Kusowska, Magdalena Winiarska & Małgorzata Bobrowicz. (2022) In Vitro Diffuse Large B-Cell Lymphoma Cell Line Models as Tools to Investigate Novel Immunotherapeutic Strategies. Cancers 15:1, pages 235.
Crossref
Yunying Zhu, Chenshuang Lei, Qian Jiang, Qinhua Yu & Liannv Qiu. (2022) DSF/Cu induces antitumor effect against diffuse large B-cell lymphoma through suppressing NF-κB/BCL6 pathways. Cancer Cell International 22:1.
Crossref
Leyre Bento, Oliver Vögler, Adriana Sas-Barbeito, Josep Muncunill, Teresa Ros, Jordi Martínez, Adriana Quintero-Duarte, Rafael Ramos, Víctor Jose Asensio, Concepción Fernández-Rodríguez, Antonio Salar, Alfons Navarro, Raquel del Campo, Javier Ibarra, Regina Alemany & Antonio Gutiérrez. (2022) Screening for Prognostic microRNAs Associated with Treatment Failure in Diffuse Large B Cell Lymphoma. Cancers 14:4, pages 1065.
Crossref
Anke Maes, Ken Maes, Philip Vlummens, Hendrik De Raeve, Julie Devin, Vanessa Szablewski, Kim De Veirman, Eline Menu, Jerome Moreaux, Karin Vanderkerken & Elke De Bruyne. (2019) Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma. Blood Cancer Journal 9:12.
Crossref
Katrin Pansy, Julia Feichtinger, Barbara Ehall, Barbara Uhl, Miriam Sedej, David Roula, Beata Pursche, Axel Wolf, Manuel Zoidl, Elisabeth Steinbauer, Verena Gruber, Hildegard T Greinix, Katharina T. Prochazka, Gerhard G. Thallinger, Akos Heinemann, Christine Beham-Schmid, Peter Neumeister, Tanja M. Wrodnigg, Karoline Fechter & Alexander JA. Deutsch. (2019) The CXCR4–CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro. International Journal of Molecular Sciences 20:19, pages 4740.
Crossref
Martina Vockerodt, Katerina Vrzalikova, Maha Ibrahim, Eszter Nagy, Sandra Margielewska, Robert Hollows, Lauren Lupino, Reuben Tooze, Matthew Care, William Simmons, Alexandra Schrader, Tracey Perry, Maizaton Abdullah, Stephen Foster, Gary Reynolds, Alexander Dowell, Zbigniew Rudzki, Daniel Krappmann, Dieter Kube, Ciaran Woodman, Wenbin Wei, Graham Taylor & Paul G Murray. (2019) Regulation of S1PR2 by the EBV oncogene LMP1 in aggressive ABC‐subtype diffuse large B‐cell lymphoma. The Journal of Pathology 248:2, pages 142-154.
Crossref
Hiresh Ayoubian, Nicole Ludwig, Tobias Fehlmann, Jennifer Menegatti, Laura Gröger, Eleni Anastasiadou, Pankaj Trivedi, Andreas Keller, Eckart Meese & Friedrich A. Grässer. (2019) Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex. Journal of Virology 93:3.
Crossref
Thea Kristin Våtsveen, Marit Renée Myhre, Chloé Beate Steen, Sébastien Wälchli, Ole Christian Lingjærde, Baoyan Bai, Pierre Dillard, Theodossis A. Theodossiou, Toril Holien, Anders Sundan, Else Marit Inderberg, Erlend B. Smeland, June Helen Myklebust & Morten P. Oksvold. (2018) Artesunate shows potent anti-tumor activity in B-cell lymphoma. Journal of Hematology & Oncology 11:1.
Crossref
Hans G. Drexler, Claudia Pommerenke, Sonja Eberth & Stefan Nagel. (2018) Hodgkin lymphoma cell lines: to separate the wheat from the chaff. Biological Chemistry 399:6, pages 511-523.
Crossref
Julia Alles, Nicole Ludwig, Stefanie Rheinheimer, Petra Leidinger, Friedrich A. Grässer, Andreas Keller & Eckart Meese. (2017) MiR-148a impairs Ras/ERK signaling in B lymphocytes by targeting SOS proteins. Oncotarget 8:34, pages 56417-56427.
Crossref
Hongfeng Yuan, Meilan He, Fan Cheng, Rosemary Bai, Suzane Ramos da Silva, Ricardo C.T. Aguiar & Shou-Jiang Gao. (2017) Tenovin-6 inhibits proliferation and survival of diffuse large B-cell lymphoma cells by blocking autophagy. Oncotarget 8:9, pages 14912-14924.
Crossref
Maryam Delforoush, Sara Strese, Malin Wickström, Rolf Larsson, Gunilla Enblad & Joachim Gullbo. (2016) In vitro and in vivo activity of melflufen (J1) in lymphoma. BMC Cancer 16:1.
Crossref
Keiki Sugimoto, Fumihiko Hayakawa, Satoko Shimada, Takanobu Morishita, Kazuyuki Shimada, Tomoya Katakai, Akihiro Tomita, Hitoshi Kiyoi & Tomoki Naoe. (2015) Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cells. Scientific Reports 5:1.
Crossref
Andreas Hofmann, Thore Thiesler, Bertran Gerrits, Silvia Behnke, Nadine Sobotzki, Ulrich Omasits, Damaris Bausch-Fluck, Thomas Bock, Ruedi Aebersold, Holger Moch, Marianne Tinguely & Bernd Wollscheid. (2015) Surfaceome of classical Hodgkin and non-Hodgkin lymphoma. PROTEOMICS - Clinical Applications 9:7-8, pages 661-670.
Crossref
Fazila AsmarChristoffer HotherGorjan KulosmanMarianne Bach TreppendahlHelene Myrtue NielsenUlrik RalfkiaerAnja PedersenMichael Boe MøllerElisabeth RalfkiaerPeter de Nully BrownKirsten Grønbæk. (2014) Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another “double hit” lymphoma with very poor outcome? . Oncotarget 5:7, pages 1912-1925.
Crossref
Paola BonettiMonica TestoniMarta ScandurraMaurilio PonzoniRoberto PivaAfua A. MensahAndrea RinaldiIvo KweeMaria Grazia TibilettiJaveed IqbalTimothy C. GreinerWing-Chung ChanGianluca GaidanoMiguel A. Piris, Franco CavalliEmanuele ZuccaGiorgio InghiramiFrancesco Bertoni. (2013) Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma. Blood 122:13, pages 2233-2241.
Crossref
H Quentmeier, R M Amini, M Berglund, W G Dirks, S Ehrentraut, R Geffers, R A F MacLeod, S Nagel, J Romani, M Scherr, M Zaborski & H G Drexler. (2012) U-2932: two clones in one cell line, a tool for the study of clonal evolution. Leukemia 27:5, pages 1155-1164.
Crossref
P Rosato, E Anastasiadou, N Garg, D Lenze, F Boccellato, S Vincenti, M Severa, E M Coccia, R Bigi, M Cirone, E Ferretti, A F Campese, M Hummel, L Frati, C Presutti, A Faggioni & P Trivedi. (2012) Differential regulation of miR-21 and miR-146a by Epstein–Barr virus-encoded EBNA2. Leukemia 26:11, pages 2343-2352.
Crossref
Sung‐Hsin Kuo, Wen‐Hui Weng, Zi‐Hua Chen, Ping‐Ning Hsu, Ming‐Shiang Wu, Chung‐Wu Lin, Huei‐Jiuan Jeng, Kun‐Huei Yeh, Hui‐Jen Tsai, Li‐Tzong Chen & Ann‐Lii Cheng. (2011) Establishment of a novel MALT lymphoma cell line, ma‐1, from a patient with t(14;18)(q32;q21)‐positive Helicobacter Pylori ‐Independent Gastric MALT Lymphoma . Genes, Chromosomes and Cancer 50:11, pages 908-921.
Crossref
Christian Steidl & Randy D. Gascoyne. (2011) The molecular pathogenesis of primary mediastinal large B-cell lymphoma. Blood 118:10, pages 2659-2669.
Crossref
Giulia Poretti, Ivo Kwee, Barbara Bernasconi, Paola M.V. Rancoita, Andrea Rinaldi, Carlo Capella, Emanuele Zucca, Antonino Neri, Maria Grazia Tibiletti & Francesco Bertoni. (2011) Chromosome 11q23.1 is an unstable region in B-cell tumor cell lines. Leukemia Research 35:6, pages 808-813.
Crossref
Christian Steidl, Sohrab P. Shah, Bruce W. Woolcock, Lixin Rui, Masahiro Kawahara, Pedro Farinha, Nathalie A. Johnson, Yongjun Zhao, Adele Telenius, Susana Ben Neriah, Andrew McPherson, Barbara Meissner, Ujunwa C. Okoye, Arjan Diepstra, Anke van den Berg, Mark Sun, Gillian Leung, Steven J. Jones, Joseph M. Connors, David G. Huntsman, Kerry J. Savage, Lisa M. Rimsza, Douglas E. Horsman, Louis M. Staudt, Ulrich Steidl, Marco A. Marra & Randy D. Gascoyne. (2011) MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 471:7338, pages 377-381.
Crossref
E Anastasiadou, F Boccellato, S Vincenti, P Rosato, I Bozzoni, L Frati, A Faggioni, C Presutti & P Trivedi. (2009) Epstein–Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b. Oncogene 29:9, pages 1316-1328.
Crossref
Michael C. FlickingerKenneth Barry Walker & Angela Rodgers. 2009. Encyclopedia of Industrial Biotechnology. Encyclopedia of Industrial Biotechnology 1 8 .
Norafiza Zainuddin, Mattias Berglund, Alkwin Wanders, Zhi-Ping Ren, Rose-Marie Amini, Monica Lindell, Meena Kanduri, Göran Roos, Richard Rosenquist & Gunilla Enblad. (2009) TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype. Leukemia Research 33:1, pages 60-66.
Crossref
Francesco Boccellato, Eleni Anastasiadou, Paola Rosato, Bettina Kempkes, Luigi Frati, Alberto Faggioni & Pankaj Trivedi. (2007) EBNA2 Interferes with the Germinal Center Phenotype by Downregulating BCL6 and TCL1 in Non-Hodgkin's Lymphoma Cells. Journal of Virology 81:5, pages 2274-2282.
Crossref
Clara Sambade, Mattias Berglund, Svetlana Lagercrantz, Jan Sällström, Rui M. Reis, Gunilla Enblad, Bengt Glimelius & Christer Sundström. (2006) U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma. International Journal of Cancer 118:3, pages 555-563.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.